Lv1
30 积分 2025-08-22 加入
Intranasal Carrier-Free Nanomodulator Addresses Both Symptomatology and Etiology of Alzheimer's Disease by Restoring Neuron Plasticity and Reprogramming Lesion Microenvironment
2个月前
已完结
Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network
2个月前
已完结
Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease
5个月前
已完结
Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease
10个月前
已完结
皖公网安备34019202002308
